2018
DOI: 10.7599/hmr.2018.38.1.27
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative Blood Management: Pros and Cons of ANH and Cell Salvage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…Up to the present day, conventional therapies with antimicrobial agents are used to treat and prevent the associated infections; however, the professionals disagree on the origin of the cardiac patient’s infections during the post-operative period, based on the existing data. Furthermore, recent research studies assert that, under certain conditions, the effectiveness and benefits for the patients from using the cell saver under extra-body circulation are ambiguous, with discrepancies among the studies or the patients ( 31 ) . Not to mention the current safety problems in cases of severe bacterial contamination where future studies will be needed to better determine how and when the cell saver is to be used, alongside with new blood conservation measures ( 32 ) .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Up to the present day, conventional therapies with antimicrobial agents are used to treat and prevent the associated infections; however, the professionals disagree on the origin of the cardiac patient’s infections during the post-operative period, based on the existing data. Furthermore, recent research studies assert that, under certain conditions, the effectiveness and benefits for the patients from using the cell saver under extra-body circulation are ambiguous, with discrepancies among the studies or the patients ( 31 ) . Not to mention the current safety problems in cases of severe bacterial contamination where future studies will be needed to better determine how and when the cell saver is to be used, alongside with new blood conservation measures ( 32 ) .…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, recent research studies assert that, under certain conditions, the effectiveness and benefits for the patients from using the cell saver under extra-body circulation are ambiguous, with discrepancies among the studies or the patients (31) . Not to mention the current safety problems in cases of severe bacterial contamination where future studies will be needed to better determine how and when the cell saver is to be used, alongside with new blood conservation measures (32) .…”
Section: Methodsmentioning
confidence: 99%